Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dantrium
2. Dantrolene
3. Dantrolene Sodium
4. Sodium, Dantrolene
1. Dantrolene Sodium
2. 14663-23-1
3. Tox21_500424
4. Ccg-221728
5. Ncgc00261109-01
6. Ac-25752
7. D 9175
Molecular Weight | 336.23 g/mol |
---|---|
Molecular Formula | C14H9N4NaO5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 336.04706368 g/mol |
Monoisotopic Mass | 336.04706368 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 530 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Dantrolene sodium |
Drug Label | The chemical formula of dantrolene sodium is hydrated 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2, 4-imidazolidinedione sodium salt. It is an orange powder, slightly soluble in water, but due to its slightly acidic nature the solubility incre... |
Active Ingredient | Dantrolene sodium |
Dosage Form | Capsule |
Route | Oral |
Strength | 100mg; 25mg; 50mg |
Market Status | Prescription |
Company | Mikah Pharma; Impax Labs |
2 of 2 | |
---|---|
Drug Name | Dantrolene sodium |
Drug Label | The chemical formula of dantrolene sodium is hydrated 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2, 4-imidazolidinedione sodium salt. It is an orange powder, slightly soluble in water, but due to its slightly acidic nature the solubility incre... |
Active Ingredient | Dantrolene sodium |
Dosage Form | Capsule |
Route | Oral |
Strength | 100mg; 25mg; 50mg |
Market Status | Prescription |
Company | Mikah Pharma; Impax Labs |
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : Gurvey & Berry offers an impressive lineup of bulk raw materials, but we are much more than products by the kilo or tonne. With 4 decades behind us, and our Service First philosoph...
About the Company : Lewens Labs finds its roots in 4 years of engineering during which we saw a dream to carve out a niche for ourselves in Pharmaceutical Industry. As a part of the final year project...
About the Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Active Pharmaceutical Ing...
About the Company : ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a w...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : No
TE Code :
Brand Name : DANTROLENE SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Approval Date : 2016-02-18
Application Number : 205239
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : RYANODEX
Dosage Form : FOR SUSPENSION;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Approval Date : 2014-07-22
Application Number : 205579
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code : AB
Brand Name : DANTROLENE SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : 25MG
Approval Date : 2005-10-24
Application Number : 76686
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DANTROLENE SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Approval Date : 2005-10-24
Application Number : 76686
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DANTROLENE SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Approval Date : 2005-10-24
Application Number : 76686
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AP
Brand Name : DANTROLENE SODIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Approval Date : 2017-06-19
Application Number : 204762
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AB
Brand Name : DANTROLENE SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : 25MG
Approval Date : 2005-03-01
Application Number : 76856
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DANTROLENE SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Approval Date : 2005-03-01
Application Number : 76856
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AP
Brand Name : REVONTO
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Approval Date : 2007-07-24
Application Number : 78378
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Brand Name : DANTRIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Approval Date : 1982-01-01
Application Number : 17443
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DANTROLENE SODIUM FOR INJECTION, USP
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date :
Application Number : 2529998
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DANTRIUM CAPSULES
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging : 100
Approval Date :
Application Number : 1997602
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DANTRIUM INTRAVENOUS
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date :
Application Number : 1997572
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Dantrium
Dosage Form :
Dosage Strength :
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Dantrium vial 20mg
Dosage Form : INJ
Dosage Strength : 20mg
Packaging : 12X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Dantrium iv
Dosage Form : INJ
Dosage Strength : 20mg/vial
Packaging : 1X1mg/vial
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Dantrium
Dosage Form : CAP
Dosage Strength : 25mg
Packaging : 50X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Dantrium iv
Dosage Form : INJ
Dosage Strength : 3000mg/vial
Packaging : 1X1mg/vial
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : Brazil
Brand Name : DANTROLENE
Dosage Form : INJECTION
Dosage Strength : 20MG
Packaging : 12 VIALS + 12 AMPS OIL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Brazil
Packaging : 12 VIALS + 12 AMPS OIL
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 20MG
Brand Name : DANTROLENE
Approval Date :
Application Number :
Registration Country : Brazil
Regulatory Info : Generic
Registration Country : Brazil
Brand Name : DANTROLENE
Dosage Form : INJECTION
Dosage Strength : 20MG
Packaging : 12 VIALS + 12 AMPS OIL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Brazil
Packaging : 12 VIALS + 12 AMPS OIL
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 20MG
Brand Name : DANTROLENE
Approval Date :
Application Number :
Registration Country : Brazil
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Company :
Dantrolene Sodium
Drug Cost (USD) : 17,162
Year : 2022
Prescribers : 12
Prescriptions : 85
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 4,248,624
Year : 2022
Prescribers : 6323
Prescriptions : 42915
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 26,804
Year : 2021
Prescribers : 23
Prescriptions : 141
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 4,378,821
Year : 2021
Prescribers : 6366
Prescriptions : 44050
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 4,898,845
Year : 2020
Prescribers : 6465
Prescriptions : 46078
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 29,516
Year : 2020
Prescribers : 19
Prescriptions : 134
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 37,988
Year : 2019
Prescribers : 28
Prescriptions : 174
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 4,933,986
Year : 2019
Prescribers : 6627
Prescriptions : 46852
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 35,987
Year : 2018
Prescribers : 34
Prescriptions : 205
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Dantrolene Sodium
Drug Cost (USD) : 4,839,531
Year : 2018
Prescribers : 6605
Prescriptions : 47874
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
74
PharmaCompass offers a list of Dantrolene API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dantrolene manufacturer or Dantrolene supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dantrolene manufacturer or Dantrolene supplier.
PharmaCompass also assists you with knowing the Dantrolene API Price utilized in the formulation of products. Dantrolene API Price is not always fixed or binding as the Dantrolene Price is obtained through a variety of data sources. The Dantrolene Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dantrolene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dantrolene, including repackagers and relabelers. The FDA regulates Dantrolene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dantrolene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dantrolene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dantrolene supplier is an individual or a company that provides Dantrolene active pharmaceutical ingredient (API) or Dantrolene finished formulations upon request. The Dantrolene suppliers may include Dantrolene API manufacturers, exporters, distributors and traders.
click here to find a list of Dantrolene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dantrolene DMF (Drug Master File) is a document detailing the whole manufacturing process of Dantrolene active pharmaceutical ingredient (API) in detail. Different forms of Dantrolene DMFs exist exist since differing nations have different regulations, such as Dantrolene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dantrolene DMF submitted to regulatory agencies in the US is known as a USDMF. Dantrolene USDMF includes data on Dantrolene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dantrolene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dantrolene suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dantrolene as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dantrolene API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dantrolene as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dantrolene and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dantrolene NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dantrolene suppliers with NDC on PharmaCompass.
Dantrolene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dantrolene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dantrolene GMP manufacturer or Dantrolene GMP API supplier for your needs.
A Dantrolene CoA (Certificate of Analysis) is a formal document that attests to Dantrolene's compliance with Dantrolene specifications and serves as a tool for batch-level quality control.
Dantrolene CoA mostly includes findings from lab analyses of a specific batch. For each Dantrolene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dantrolene may be tested according to a variety of international standards, such as European Pharmacopoeia (Dantrolene EP), Dantrolene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dantrolene USP).